Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Rodon J, Perez-Fidalgo A, Krop IE, Burris H, et al. Phase 1/1b dose escalation and expansion study of BEZ235, a dual PI3K/mTOR inhibitor, in patients with advanced solid tumors including patients with advanced breast cancer. Cancer Chemother Pharmacol 2018 Jun 7. pii: 10.1007/s00280-018-3610.
PMID: 29882016


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016